All Stories

  1. Challenges in the Management of Asthma and COPD in the Asia‐Pacific Region
  2. Climate Change and Respiratory Care With Inhalers
  3. Prevalence and correlates of breathlessness in adults: an umbrella review and updated systematic review with meta-analysis in general and clinical populations
  4. Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
  5. COPD and Lung Cancer: Shared Risks and Connections
  6. Ground-Glass Opacities on Computed Tomography of the Thorax to Predict Progression of Emphysema: Are We There Yet?
  7. Green energy and sustainability
  8. Exhaled biomarkers for respiratory diseases
  9. Clinical characteristics and healthcare resource utilization in patients with chronic obstructive pulmonary disease in Hong Kong
  10. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients
  11. ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (FENO50)
  12. Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life
  13. Clinical characteristics of patients with COPD in Hong Kong
  14. Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis
  15. Retrospective comparison of the clinical outcomes between low and standard starting doses of intrapleural tissue plasminogen activator in pleural infection
  16. To determine the efficacy of autologous blood patch therapy in reducing air leak in secondary spontaneous pneumothorax.
  17. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
  18. Can we predict asthma exacerbations?
  19. Risk of air and surface contamination during application of different noninvasive respiratory support for patients with COVID-19
  20. Minimize systemic oral corticosteroids use and reduce harm for patients with asthma
  21. 1-Year Prospective Study of the Relationship of Serial Exhaled Nitric Oxide Level and Asthma Control
  22. GOLD 2023 executive summary: comments from Asia's perspective
  23. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study
  24. Smoking: Quit to win
  25. A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma [Corrigendum]
  26. Hospital Burden of Chronic Obstructive Pulmonary Disease in Hong Kong – The Trend from 2006 to 2014
  27. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
  28. Phenotyping empyema by pleural fluid culture results and macroscopic appearance: an 8-year retrospective study
  29. Severe asthma, more than that?
  30. A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma
  31. Advancement of asthma management in the past decade
  32. Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection
  33. Aspergillus sensitization as a treatable trait in COPD
  34. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
  35. Would chronic mucus hypersecretion affect the clinical response to medications of COPD patients?
  36. Leading women in respiratory medicine: The role of the APSR in promoting gender equity and inclusiveness
  37. Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates
  38. Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD
  39. SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022
  40. Effect of Weight Loss and Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Metabolic Profile Stratified by Craniofacial Phenotype: A Randomized Clinical Trial
  41. Virus neutralization of SARS-CoV-2 Omicron variant BA.2 in those vaccinated with three doses of BNT162b2 or CoronaVac vaccines.
  42. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
  43. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
  44. Global Initiative for Asthma Strategy 2021
  45. Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes
  46. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
  47. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
  48. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
  49. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade
  50. Prologue to leading women in respiratory medicine series
  51. A territory‐wide study on the factors associated with recurrent asthma exacerbations requiring hospitalization in Hong Kong
  52. Reply
  53. Predictive value of blood eosinophil count in COPD
  54. Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial
  55. Evaluation of bronchial challenge test results for use in assessment of paediatric eczema: a retrospective series
  56. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
  57. ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)
  58. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
  59. Characterisation of patients hospitalised for asthma exacerbations in Hong Kong
  60. “High-Risk” Clinical and Inflammatory Clusters in COPD of Chinese Descent
  61. Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD : A randomized controlled trial
  62. Time course of blood oxygen saturation responding to short-term fine particulate matter among elderly healthy subjects and patients with chronic obstructive pulmonary disease
  63. Real-Time Monitoring of the Effects of Personal Temperature Exposure on the Blood Oxygen Saturation Level in Elderly People with and without Chronic Obstructive Pulmonary Disease: A Panel Study in Hong Kong
  64. Fungal Sensitization and Its Association with Frequent Exacerbations in COPD
  65. Inflammatory Phenotypes in Chronic Obstructive Pulmonary Disease (COPD) of Chinese Descent
  66. Obstructive Sleep Apnea and CPAP Treatment Response in Patients with Non Alcoholic Fatty Liver Disease
  67. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD
  68. Asthma–COPD overlap: No formal definition and simple diagnostic tool so far?
  69. Twenty‐five years of Respirology : Advances in COPD
  70. Comprehensive care for chronic obstructive pulmonary disease
  71. Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes
  72. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease
  73. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations
  74. GINA 2019: a fundamental change in asthma management
  75. Prevalence and burden of asthma in China: time to act
  76. Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission
  77. Author Correction: A randomized controlled trial of an ambulatory approach versus the hospital-based approach in managing suspected obstructive sleep apnea syndrome
  78. Use of Berlin questionnaire in comparison to polysomnography and home sleep study in patients with obstructive sleep apnea
  79. The interaction between hypertension and obstructive sleep apnea on subjective daytime sleepiness
  80. Exhaled air dispersion from high flow nasal cannula (HFNC) vs CPAP
  81. COMBINATION OF NON CPAP THERAPY IN PATIENTS WITH OSA
  82. Short-course pulmonary rehabilitation and exacerbations and activity of COPD patients over 1 year
  83. Continuous positive airway pressure for obstructive sleep apnoea does not improve asthma control
  84. Identification of chronic obstructive pulmonary disease subgroups in 13 Asian cities
  85. Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong – computerized data collection and analysis
  86. CC16 levels correlate with cigarette smoke exposure in bronchial epithelial cells and with lung function decline in smokers
  87. Year in review 2017: Chronic obstructive pulmonary disease and asthma
  88. Exhaled air dispersion during bag-mask ventilation and sputum suctioning - Implications for infection control
  89. Adherence to a COPD treatment guideline among patients in Hong Kong
  90. Many patients labelled as having mild asthma do not have well-controlled asthma
  91. Drug Treatment for Early-Stage COPD
  92. Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS
  93. The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma
  94. A randomized controlled trial of an ambulatory approach versus the hospital-based approach in managing suspected obstructive sleep apnea syndrome
  95. Year in review 2016: Chronic obstructive pulmonary disease and asthma
  96. Effects of CPAP therapy on visceral fat thickness, carotid intima-media thickness and adipokines in patients with obstructive sleep apnoea
  97. Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections
  98. Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial
  99. Acute exacerbation of COPD
  100. Year in review 2015: Asthma and chronic obstructive pulmonary disease
  101. Genetic effects of multiple asthma loci identified by genomewide association studies on asthma and spirometric indices
  102. Mesenteric fat thickness is associated with metabolic syndrome independently of Apnoea-Hypopnoea Index in subjects with obstructive sleep apnoea
  103. A Randomized Controlled Study to Examine the Effect of a Lifestyle Modification Program in OSA
  104. Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress
  105. Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT)
  106. Prevalence of obstructive sleep apnea syndrome and CPAP adherence in the elderly Chinese population
  107. A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea
  108. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer
  109. Suicidal ideation in Chinese patients with chronic obstructive pulmonary disease: a controlled study
  110. Exhaled Air Dispersion During Noninvasive Ventilation via Helmets and a Total Facemask
  111. Prevalence of Obstructive Sleep Apnea Syndrome and CPAP Adherence in the Elderly Chinese Population
  112. Year in review 2014: Chronic obstructive pulmonary disease, asthma and airway biology
  113. COPD care programme can reduce readmissions and in-patient bed days
  114. Quality of Life in Older Patients With Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study
  115. Year in review 2013: Chronic obstructive pulmonary disease, asthma and airway biology
  116. Early dislodgement of Indwelling Pleural Catheter ( IPC ): a balancing act
  117. Differences in asthma genetics between Chinese and other populations
  118. Insomnia in Older Adults with Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study
  119. Mesenteric fat thickness is associated with increased risk of obstructive sleep apnoea
  120. Depressive disorders in older patients with chronic obstructive pulmonary disease (COPD) in Hong Kong: a controlled study
  121. Recent advances in asthma biomarker research
  122. Year in review 2012: Asthma and chronic obstructive pulmonary disease
  123. An Adjunct Intervention for Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
  124. Diagnosis of silicotuberculosis by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA)
  125. Changing Prevalence of Allergic Diseases in the Asia-Pacific Region
  126. Determinants of, and reference equation for, exhaled nitric oxide in the Chinese population
  127. Asthma and bronchodilator responsiveness are associated with polymorphic markers of ARG1, CRHR2 and chromosome 17q21
  128. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese
  129. Air pollution and chronic obstructive pulmonary disease
  130. Year in review 2011: Asthma, chronic obstructive pulmonary disease and airway biology
  131. Evaluation of the asthma control test: A reliable determinant of disease stability and a predictor of future exacerbations
  132. A prospective cohort study of the long-term effects of CPAP on carotid artery intima-media thickness in Obstructive sleep apnea syndrome
  133. Roles of pollution in the prevalence and exacerbations of allergic diseases in Asia
  134. Erratum to: Atopy in Children with Eczema
  135. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD
  136. Relationship between asthma control status, the Asthma Control Test™ and urgent health-care utilization in Asia
  137. A longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD
  138. Gene-gene Interactions for Asthma and Bronchodilator Responsiveness in Chinese Adults
  139. The lower the body weight for COPD patients, the more effective is pulmonary rehabilitation?
  140. Effect of Acu-TENS on Post-exercise Expiratory Lung Volume in Subjects with Asthma – a randomized controlled trial
  141. Effects of Air Pollution on Lung Health
  142. PRS11 COST ANALYSIS OF DIFFERENT PHARMACOTHERAPIES IN SUBJECTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE PUBLIC SECTOR OF HONG KONG
  143. Prevalence of Sleep-Disordered Breathing in Chinese Elderly
  144. Can continuous pump feeding reduce the incidence of pneumonia in nasogastric tube-fed patients? A randomized controlled trial
  145. Effect of 4 weeks of Acu-TENS on functional capacity and β-endorphin level in subjects with chronic obstructive pulmonary disease: A randomized controlled trial
  146. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status
  147. Atopy in children with eczema
  148. Validation of Embletta portable diagnostic system for identifying patients with suspected obstructive sleep apnoea syndrome (OSAS)
  149. CXCL 9 and CXCL 10 as Sensitive Markers of Disease Activity in Patients with Rheumatoid Arthritis
  150. Effect of Acu-TENS on post-exercise expiratory lung volume in subjects with asthma—A randomized controlled trial
  151. Asthma Control Test correlates well with the treatment decisions made by asthma specialists
  152. Predicting changes in clinical status of young asthmatics: Clinical scores or objective parameters?
  153. Outdoor air pollution: impact on chronic obstructive pulmonary disease patients
  154. Pulmonary scedosporium infection as a complication of infliximab therapy for ankylosing spondylitis
  155. Activation of Peripheral Th17 Lymphocytes in Patients with Asthma
  156. Identifying Uncontrolled Asthma in Young Children: Clinical Scores or Objective Variables?
  157. Expression and Functional Analysis of Toll-Like Receptors of Peripheral Blood Cells in Asthmatic Patients: Implication for Immunopathological Mechanism in Asthma
  158. Measurement of tumor necrosis factor-α, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease
  159. Patterns of food and aeroallergen sensitization in childhood eczema
  160. Prevalence and risk factors of airflow obstruction in an elderly Chinese population
  161. Validation of a portable recording device (ApneaLink) for identifying patients with suspected obstructive sleep apnoea syndrome
  162. The burden of lung disease in Hong Kong: A report from the Hong Kong Thoracic Society
  163. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia
  164. Sonographic Measurement of Lateral Parapharyngeal Wall Thickness in Patients with Obstructive Sleep Apnea
  165. Viral Etiology of Acute Exacerbations of COPD in Hong Kong
  166. Effects of air pollution on asthma hospitalization rates in different age groups in Hong Kong
  167. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong
  168. Reference values of diffusing capacity of non-smoking Chinese in Hong Kong
  169. Increased Expression of Plasma and CD4+ T Lymphocyte Costimulatory Molecule CD26 in Adult Patients with Allergic Asthma
  170. Eczema exacerbation and food atopy beyond infancy: How should we advise Chinese parents about dietary history, eczema severity, and skin prick testing?
  171. Decreased T-bet expression and changes in chemokine levels in adults with asthma
  172. A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized With Acute Exacerbations of COPD
  173. Are exhaled breath condensates useful in monitoring asthma?
  174. Polymorphisms in the IL-4, IL-4 Receptor α Chain, TNF-α, and Lymphotoxin-α Genes and Risk of Asthma in Hong Kong Chinese Adults
  175. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness
  176. Sleep-disordered breathing and continuous positive airway pressure compliance in a group of commercial bus drivers in Hong Kong
  177. 12-year change in prevalence of respiratory symptoms in elderly Chinese living in Hong Kong
  178. Response by J.C.W. Mak, H.C.M. Leung, S.P. Ho, F.W.S. Ko, A.H.K. Cheung, M.S.M. Ip and M.M.W. Chan‐Yeung
  179. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene α and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease
  180. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients
  181. Aberrant Expression of CC and CXC Chemokines and Their Receptors in Patients with Asthma
  182. Increasing COPD awareness
  183. Updated Spirometric Reference Values for Adult Chinese in Hong Kong and Implications on Clinical Utilization
  184. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients.
  185. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong
  186. Wheezing in Chinese schoolchildren: disease severity distribution and management practices, a community-based study in Hong Kong and Guangzhou
  187. Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis
  188. Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children
  189. The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors
  190. DETERMINING THE LOWER LIMITS OF NORMAL OF SPIROMETRIC REFERENCE VALUES FOR ADULT CHINESE IN HONG KONG
  191. THE LONG-TERM IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) ON PULMONARY FUNCTION, EXERCISE CAPACITY, AND QUALITY OF LIFE IN A COHORT OF SURVIVORS
  192. High levels and gender difference of exhaled nitric oxide in Chinese schoolchildren
  193. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma
  194. A Comparison of Airway and Serum Matrix Metalloproteinase-9 Activity Among Normal Subjects, Asthmatic Patients, and Patients With Asthmatic Mucus Hypersecretion
  195. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors
  196. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong
  197. Analysis of Growth Factors and Inflammatory Cytokines in Exhaled Breath Condensate from Asthmatic Children
  198. Declining asthma prevalence in Hong Kong Chinese schoolchildren
  199. Factors associated with difference in prevalence of asthma in children from three cities in China: multicentre epidemiological survey
  200. Early results of endoscopic lung volume reduction for emphysema
  201. The Effects of Nasal Continuous Positive Airway Pressure on Platelet Activation in Obstructive Sleep Apnea Syndrome
  202. Akute Exazerbation der COPD
  203. Increased macrophage‐derived chemokine in exhaled breath condensate and plasma from children with asthma
  204. Analysis of Th2-specific chemokines in exhaled breath condensate from asthmatic children*1
  205. Cephalometric assessment of craniofacial morphology in Chinese patients with obstructive sleep apnoea
  206. Apoptosis and B-Cell Lymphoma-2 of Peripheral Blood T Lymphocytes and Soluble Fas in Patients with Allergic Asthma
  207. Prevalence of Sleep-Disordered Breathing and Continuous Positive Airway Pressure Compliance
  208. Prevalence of wheeze, bronchial hyper-responsiveness and asthma in the elderly Chinese
  209. Prevalence of snoring and sleep-disordered breathing in a group of commercial bus drivers in Hong Kong
  210. Severe Obstructive Sleep Apnea Is Associated With Left Ventricular Diastolic Dysfunction
  211. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ , IL-4, IL-10 and IL-13) in patients with allergic asthma
  212. Determinants of Continuous Positive Airway Pressure Compliance in a Group of Chinese Patients With Obstructive Sleep Apnea
  213. Temporal relationship between air pollution and hospital admissions for asthmatic children in Hong Kong
  214. Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis
  215. Effects of Augmented Continuous Positive Airway Pressure Education and Support on Compliance and Outcome in a Chinese Population
  216. Effects of theophylline, dexamethasone and salbutamol on cytokine gene expression in human peripheral blood CD4+ T-cells
  217. Evaluation of the efficacy of a hospital‐based asthma education programme in patients of low socioeconomic status in Hong Kong